Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 609 of 6351
-
Twice-Yearly shot aims to cut heart attacks and amputations
Disease control Recruiting nowV-INTERVENTION will evaluate the effectiveness of inclisiran in preventing major cardiovascular and limb events in patients receiving percutaneous coronary or peripheral arterial revascularization. Inclisiran is a subcutaneous, twice-yearly injection that is FDA-approved as an ad…
Phase 4 • Sponsor: Duke University • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Electric shocks + chemo: new hope for inoperable tumors?
Disease control Recruiting nowThis is an monocenter, single arm, clinical investigation that evaluate the impact of the method on the objective response rate (ORR) of visceral lesions undergoing electrochemotherapy. Electrochemotherapy is a well-defined method for the treatment of cutaneous and subcutaneous m…
Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New hope for older leukemia patients: gentler chemo shows promise
Disease control Recruiting nowAcute lymphoblastic leukemia (ALL) is characterized by the abnormal proliferation of immature precursor cells, disrupting normal hematopoiesis and causing severe anemia and thrombocytopenia due to genetic mutations. Conventional treatment with intensive chemotherapy is limited fo…
Sponsor: Hospital General de Mexico • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
AI-Powered ECG reading aims to catch heart failure sooner
Diagnosis Recruiting nowThe DECISION trial aims to evaluate the efficacy of an artificial intelligence (AI)-powered system, Willem™, for improving the detection of heart failure (HF) in primary care settings by interpreting electrocardiograms (ECGs). The study seeks to answer whether AI-assisted ECG int…
Sponsor: Idoven 1903 S.L. • Aim: Diagnosis
Last updated Jul 22, 2026 00:00 UTC
-
New CAR-T therapy targets Hard-to-Treat blood cancers
Disease control Recruiting nowA Clinical Study to Explore the Safety, Efficacy, and Cellular Metabolic Dynamics of CT0596 CAR-T Cell Injection in Patients With Relapsed/Refractory Multiple Myeloma and Plasma Cell Leukemia.
Early phase 1 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New combo therapy before surgery shows promise for tough esophageal cancer
Disease control Recruiting nowEffective systemic therapy such as nivolumab as an adjuvant therapy has been demonstrated to improve the outcomes of patients receiving neoadjuvant chemoradiotherapy (CRT) for locoregional esophageal cancer. A more effective systemic therapy with anti-PD-1 or anti-PD-L1 immune ch…
Phase 2 • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New antibody shot shows promise in preventing malaria in african women
Prevention CompletedSafety and Efficacy of L9LS, a Human Monoclonal Antibody Against Plasmodium falciparum, in a Randomized, Double-Blind, Placebo-Controlled Trial of Women of Childbearing Potential (WOCBP) in Mali
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Prevention
Last updated Jun 27, 2026 13:05 UTC
-
Can magnetic pulses to the brain reverse Long-COVID smell loss, tinnitus, and fatigue?
Symptom relief Recruiting nowThe purpose of this study is to test if Variable Pulse TMS (Transcranial Magnetic Stimulation) can result in objective improvements in patients with Post COVID Syndrome (PCS).
Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
New pill combo aims to shield hearts in diabetes patients
Disease control Recruiting nowThis study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these conditions and do not have a history of heart failure. The purpose of this study is to find out if a medicine called vicadrostat, when …
Phase 3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New glasses could slow Kids' worsening eyesight
Disease control Recruiting nowThe prevalence of myopia in Singapore is among the highest in the world, with 65 percent of our children being myopic by Primary 6, and 83 percent of young adults being myopic. As such, Singapore is often labelled as the "Myopia Capital of the World". By 2050, it is projected tha…
Sponsor: Rodenstock GmbH • Aim: Disease control
Last updated Jun 26, 2026 18:34 UTC
-
Spinal gene injection aims to slow duchenne in toddlers
Disease control Recruiting nowThe primary objective of this study is to evaluate the safety and tolerability of a single dose of INS1201 via IT administration in ambulatory male participants with DMD.
Phase 1 • Sponsor: Insmed Gene Therapy LLC • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New antibody injection could ease bulging eyes in thyroid disease
Disease control Recruiting nowThe primary objective of this study is to investigate the efficacy, safety, and tolerability of MHB018A, a humanized anti-IGF1R antibody, administered q4W for 6 months, in comparison to placebo, in the treatment of participants suffering from active TED.
Phase 3 • Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Cold plasma could save limbs in diabetic patients
Disease control Recruiting nowCritical limb ischemia is the end-stage manifestation of peripheral arterial disease (PAD), frequently presenting as ischemic rest pain, ulceration, or gangrene. Diabetes mellitus is a major risk factor for lower extremity arterial occlusion, with infrapopliteal arteries most com…
Sponsor: Shenyang Medical College • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Sniffing out cancer: dogs and AI team up to detect breast cancer from breath
Diagnosis Recruiting nowThe goal of this study is to find out whether a system that uses trained detection dogs and artificial intelligence (AI) can identify breast cancer from a person's breath. Women who are scheduled to have routine breast cancer screening, such as a mammogram, ultrasound, or a biops…
Sponsor: SpotitEarly • Aim: Diagnosis
Last updated Jun 27, 2026 12:34 UTC
-
Could a Centuries-Old poison become a new weapon against a blood disorder?
Disease control Recruiting nowPhase I study with dose-escalation and expansion evaluating the safety and efficacy of oral Arsenic (ATO) in low-risk Myelodysplastic Syndromes having failed to Erythropoiesis Stimulating Agents and Luspatercept (or ineligible for the latter).
Phase 1 • Sponsor: Groupe Francophone des Myelodysplasies • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Phone-Based navigation could boost breast cancer detection in kenya
Prevention Recruiting nowThis clinical trial develops and studies how well mobile health (m-Health) patient navigation (PN) strategies work to improve screening and the early detection of breast cancer in women accessing primary care clinics in Kenya. Although highly curable, breast cancer kills thousand…
Sponsor: Emory University • Aim: Prevention
Last updated Aug 16, 2026 00:00 UTC
-
New combo therapy targets colorectal cancer in Mid-Stage trial
Disease control OngoingThe study is being conducted to evaluate the safety, tolerability and efficacy of SHR-8068 injection in combination with anti-tumor therapies in subjects with colorectal cancer.
Phase 2 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Zapping seizures away: laser treatment offers new hope for epilepsy patients
Disease control Recruiting nowHow does magnetic resonance-guided laser interstitial thermal therapy (MRgLITT) impact clinical prognosis in mesial temporal lobe epilepsy (mTLE)?
Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New drug combo aims to tackle Alzheimer's brain fog
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC for cognitive impairment in Alzheimer's Disease
Phase 3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New hope for neuroendocrine tumors: zanzalintinib takes on everolimus
Disease control Recruiting nowThe primary purpose of this study is to assess the effectiveness of zanzalintinib compared to everolimus in participants with previously treated, unresectable, locally advanced or metastatic neuroendocrine tumors.
Phase 2/3 • Sponsor: Exelixis • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC